<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>64(5)</volume><submitter>Meng X</submitter><journal>Science China. Life sciences</journal><pagination>836-839</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7518094</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Angiotensin converting enzyme inhibitors and angiotensin receptor blockers improved the outcome of patients with severe COVID-19 and hypertension.</pubmed_title><pmcid>PMC7518094</pmcid><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Zhang K</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Wei C</pubmed_authors><pubmed_authors>Zhang C</pubmed_authors><pubmed_authors>Meng X</pubmed_authors><pubmed_authors>Zhong M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Angiotensin converting enzyme inhibitors and angiotensin receptor blockers improved the outcome of patients with severe COVID-19 and hypertension.</name><description/><dates><release>2021-01-01T00:00:00Z</release><publication>2021 May</publication><modification>2025-04-25T18:34:53.597Z</modification><creation>2025-04-06T07:38:03.94Z</creation></dates><accession>S-EPMC7518094</accession><cross_references><pubmed>32975722</pubmed><doi>10.1007/s11427-020-1813-0</doi></cross_references></HashMap>